Cost-effectiveness of genomic testing for colorectal cancer: are we there yet?

Oncology (Williston Park). 2015 Mar;29(3):183-4; 186.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Colorectal Neoplasms / economics*
  • Colorectal Neoplasms / genetics*
  • Cost-Benefit Analysis*
  • Genetic Testing / economics*
  • Health Care Costs*
  • Humans

Substances

  • Biomarkers, Tumor